Danapha Pharmaceutical JSC (HSTC:DAN) Notes Receivable: ₫0.00 Mil (As of . 20)


HSTC:DAN Danapha Pharmaceutical JSC HSTC:DAN
31 GF Score
Price ₫30,300.00
! 1 Warning Sign
View Full Analysis

What is Danapha Pharmaceutical JSC Notes Receivable?

Danapha Pharmaceutical JSC HSTC:DAN 31 Notes Receivable is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:DAN with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

Danapha Pharmaceutical JSC's Notes Receivable for the quarter that ended in . 20 was ₫0.00 Mil.

Danapha Pharmaceutical JSC Notes Receivable Related Terms

Danapha Pharmaceutical JSC Notes Receivable Historical Data

* Premium members only.

The historical data trend for Danapha Pharmaceutical JSC's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danapha Pharmaceutical JSC Notes Receivable Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Notes Receivable

Danapha Pharmaceutical JSC Semi-Annual Data
Notes Receivable
HSTC:DAN
31GF Score
Danapha Pharmaceutical JSC HSTC:DAN
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danapha Pharmaceutical JSC Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₫0.00 Mil mean?
Danapha Pharmaceutical JSC (HSTC:DAN) has a Notes Receivable of ₫0.00 Mil as of . 20. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Danapha Pharmaceutical JSC and its competitors.
Is Danapha Pharmaceutical JSC's Notes Receivable too high?
Danapha Pharmaceutical JSC's current Notes Receivable is ₫0.00 Mil. Overall, Danapha Pharmaceutical JSC has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Danapha Pharmaceutical JSC's Notes Receivable compare to ZTS and UTHR?
Danapha Pharmaceutical JSC's Notes Receivable of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Danapha Pharmaceutical JSC and its competitors. Danapha Pharmaceutical JSC's current Notes Receivable is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danapha Pharmaceutical JSC stock overvalued right now?
Danapha Pharmaceutical JSC (HSTC:DAN) has a current Notes Receivable of ₫0.00 Mil. The current Notes Receivable is ₫0.00 Mil. Danapha Pharmaceutical JSC's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Danapha Pharmaceutical JSC (HSTC:DAN), the current Notes Receivable is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Danapha Pharmaceutical JSC Business Description

Address 253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
31GF Score

Get the complete analysis for HSTC:DAN

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫30,300.00
Price